DE602008004747D1 - Verfahren zur aufreinigung hydrophober proteine - Google Patents

Verfahren zur aufreinigung hydrophober proteine

Info

Publication number
DE602008004747D1
DE602008004747D1 DE602008004747T DE602008004747T DE602008004747D1 DE 602008004747 D1 DE602008004747 D1 DE 602008004747D1 DE 602008004747 T DE602008004747 T DE 602008004747T DE 602008004747 T DE602008004747 T DE 602008004747T DE 602008004747 D1 DE602008004747 D1 DE 602008004747D1
Authority
DE
Germany
Prior art keywords
proteins
hydrophous
purifying
detergent
hydroxyapatite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602008004747T
Other languages
English (en)
Inventor
Christa Tauer
Artur Mitterer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Baxter International Inc
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Publication of DE602008004747D1 publication Critical patent/DE602008004747D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602008004747T 2007-02-22 2008-02-19 Verfahren zur aufreinigung hydrophober proteine Active DE602008004747D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90280307P 2007-02-22 2007-02-22
PCT/EP2008/001284 WO2008101667A1 (en) 2007-02-22 2008-02-19 Method of purification of hydrophobic proteins

Publications (1)

Publication Number Publication Date
DE602008004747D1 true DE602008004747D1 (de) 2011-03-10

Family

ID=39346160

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602008004747T Active DE602008004747D1 (de) 2007-02-22 2008-02-19 Verfahren zur aufreinigung hydrophober proteine

Country Status (10)

Country Link
US (1) US8293876B2 (de)
EP (1) EP2129684B1 (de)
JP (1) JP5443175B2 (de)
CN (1) CN101616930B (de)
AT (1) ATE496935T1 (de)
AU (1) AU2008217189B2 (de)
CA (1) CA2677023C (de)
DE (1) DE602008004747D1 (de)
HK (1) HK1138290A1 (de)
WO (1) WO2008101667A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6227407B2 (ja) 2010-05-14 2017-11-08 バクスアルタ インコーポレイテッド Ｏｓｐａキメラおよびそのワクチンでの使用法
EP2625966A1 (de) 2012-02-13 2013-08-14 Bionanoplus, S.L. Nanopartikel mit einem pflanzlichen hydrophoben Protein und wassermischbare nichtflüchtige organische Lösung sowie Verwendungen davon
EP2841098A4 (de) 2012-04-23 2016-03-02 Allertein Therapeutics Llc Nanopartikel zur behandlung von allergien
CA2879689A1 (en) 2012-07-27 2014-01-30 Baxter International Inc. Compositions comprising chimeric ospa molecules and methods of use thereof
EP2961763A4 (de) * 2013-02-28 2016-10-12 Agency Science Tech & Res Chromatografische reinigung von antikörpern aus zellkulturerträgen mit chromatinmangel
CA2907915C (en) * 2013-04-03 2023-03-07 Allertein Therapeutics, Llc Immunomodulatory nanoparticle compositions comprising a plurality of nanoparticles comprising biodegradable or biocompatible polymers and hydrophilic and hydrophobic cellular components
JP6147340B2 (ja) * 2013-05-29 2017-06-14 Jsr株式会社 洗浄用組成物、タンパク質精製方法、及びタンパク質
SG11201603028SA (en) 2013-10-18 2016-05-30 Universität Für Bodenkultur Wien Purification of proteins
CN104710527B (zh) * 2015-02-28 2018-08-24 苏州金盟生物技术有限公司 一种生物制品的内毒素去除方法
JP2020099909A (ja) * 2020-03-17 2020-07-02 ＨＯＹＡ Ｔｅｃｈｎｏｓｕｒｇｉｃａｌ株式会社 処理方法、生産方法およびハイドロキシアパタイト充填剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861A (en) * 1848-10-17 Locking umbrella and parasol
GB8807860D0 (en) 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
US7094391B1 (en) * 1988-10-24 2006-08-22 The University Of Texas System Compositions and methods for administering Borrelia burgdorferi antigens
US5543399A (en) * 1989-08-22 1996-08-06 Hsc Research & Development Limited Partnership Cystic fibrosis transmembrane conductance regulator (CFTR) protein
US6221363B1 (en) * 1991-07-11 2001-04-24 Baxter Aktiengesellschaft Vaccine for the prevention of lyme disease
JP3158878B2 (ja) * 1994-07-28 2001-04-23 松下電器産業株式会社 光学式エンコーダ
US5846946A (en) * 1996-06-14 1998-12-08 Pasteur Merieux Serums Et Vaccins Compositions and methods for administering Borrelia DNA
US5861295A (en) * 1997-01-02 1999-01-19 Life Technologies, Inc. Nucleic acid-free thermostable enzymes and methods of production thereof
US6152944A (en) * 1997-03-05 2000-11-28 Scimed Life Systems, Inc. Catheter with removable balloon protector and stent delivery system with removable stent protector
GB9811219D0 (en) * 1998-05-26 1998-07-22 Smithkline Beecham Biolog Novel process
ES2262333T3 (es) * 1998-08-14 2006-11-16 MERCK & CO., INC. Procedimiento para purificar particulas similares a virus de papilomavirus humano.
GB0100513D0 (en) * 2001-01-09 2001-02-21 Smithkline Beecham Plc Process

Also Published As

Publication number Publication date
JP5443175B2 (ja) 2014-03-19
US20080249014A1 (en) 2008-10-09
CN101616930A (zh) 2009-12-30
EP2129684A1 (de) 2009-12-09
CN101616930B (zh) 2013-05-08
CA2677023A1 (en) 2008-08-28
ATE496935T1 (de) 2011-02-15
AU2008217189B2 (en) 2013-06-13
JP2010518836A (ja) 2010-06-03
US8293876B2 (en) 2012-10-23
HK1138290A1 (en) 2010-08-20
AU2008217189A1 (en) 2008-08-28
CA2677023C (en) 2016-08-30
WO2008101667A1 (en) 2008-08-28
EP2129684B1 (de) 2011-01-26

Similar Documents

Publication Publication Date Title
DE602008004747D1 (de) Verfahren zur aufreinigung hydrophober proteine
DE602007009295D1 (de) Verfahren zur vorbereitenden rna-reinigung mittels hplc
DE602007007666D1 (de) Verfahren zur herstellung von nebivolol
EA201001444A1 (ru) Синтез эфиров или тиоэфиров адипата
ATE538111T1 (de) Verfahren zur synthese von 5- alkoxymethylfurfuralethern
FI20115722A0 (fi) Menetelmä ja laite biologista alkuperää olevan materiaalin puhdistamiseksi
ZA200900836B (en) Process for the purification of FC-fusion proteins
ATE517192T1 (de) Verfahren zur isolierung von zellen
DK1789445T3 (da) Fremgangsmåde til fjernelse af fibronektin fra plasmafraktioner
DE602005009827D1 (de) Verfahren zur aufreinigung von il-18-bindendem protein
ATE529433T1 (de) Verfahren zur reinigung eines il-18-bindenden proteins
ATE496914T1 (de) Verfahren zur synthese von triazolen
EA201000646A1 (ru) Способ получения биопрепарата (варианты)
DE602005022099D1 (de) Fluorisierungsverfahren zur synthese von 2-ä18fü fluoro-2-deoxy-d-glukose
DK2307116T3 (da) Fremgangsmåde til selektiv ekstraktion af membranproteiner med calixarener
MY167235A (en) Fraction i-iv-1 precipitation of immunoglobins from plasma
WO2010026169A3 (de) Verfahren zum isolieren und reinigen von nukleinsäuren
ATE525466T1 (de) Verfahren und testkit zur trennung, aufreinigung und wiedergewinnung von lang- und kurzkettigen nukleinsäuren
DE602005019704D1 (de) Verfahren zur chromatographischen trennung
DE502006003169D1 (de) Verfahren zur enzymatischen Synthese von Triglyceriden
DK1842908T3 (da) Fremgangsmåde til fremstilling af oprenset lipase
DE602007005288D1 (de) Verfahren zur Reinigung von Acrylsäure
DE502006003285D1 (de) Verfahren zur auftrennung stereoisomerer verbindungen
MX2013013224A (es) Procedimiento de purificacion de proteinas de bajo ph.
IL199752A0 (en) Purification of taci-fc